Outset Medical Inc’s recent filing unveils that its Chair and CEO Trigg Leslie unloaded Company’s shares for reported $16643.0 on May 15 ’25. In the deal valued at $17.80 per share,935 shares were sold. As a result of this transaction, Trigg Leslie now holds 58,129 shares worth roughly $1.1 million.
Then, Nash Marc sold 252 shares, generating $4,491 in total proceeds. Upon selling the shares at $17.82, the SVP Operations and R&D now owns 13,465 shares.
Before that, Brottem John L. sold 396 shares. Outset Medical Inc shares valued at $7,057 were divested by the General Counsel at a price of $17.82 per share. As a result of the transaction, Brottem John L. now holds 11,273 shares, worth roughly $0.21 million.
RBC Capital Mkts downgraded its Outset Medical Inc [OM] rating to a Sector perform from a an Outperform in a research note published on August 08, 2024; the price target was decreased to $3 from $6. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in late June from “a Sector perform” to “an Outperform”. BTIG Research began covering OM with “Buy” recommendation on April 08, 2024. CL King revised its rating on April 05, 2024. It rated OM as “a Buy” which previously was an “a Neutral”.
Price Performance Review of OM
On Tuesday, Outset Medical Inc [NASDAQ:OM] saw its stock fall -7.43% to $18.94. Over the last five days, the stock has lost -8.28%. Outset Medical Inc shares have risen nearly 13.75% since the year began. Nevertheless, the stocks have fallen -67.71% over the past one year. While a 52-week high of $72.60 was reached on 01/06/25, a 52-week low of $5.85 was recorded on 03/18/25.
Levels Of Support And Resistance For OM Stock
The 24-hour chart illustrates a support level at 18.27, which if violated will result in even more drops to 17.61. On the upside, there is a resistance level at 20.18. A further resistance level may holdings at 21.43.
